risk of corona infection in india
– photo: istock
Expansion
The Covid-19 National Task Force under the Ministry of Health and Family Welfare has issued revised clinical guidelines for the management of adult citizens suffering from corona. According to the National Task Force, the revised guidelines recommend not using drugs like lopinavir-ritonavir, hydroxychloroquine (HCQ), ivermectin, molanupiravir, favipiravir, azithromycin and doxycycline.
The National Monitoring Group on COVID-19 has advised not to use plasma therapy for the treatment of adult COVID-19 patients. The National Task Force, headed by Vinod Paul, Member (Health), NITI Aayog, includes officials from the Indian Council of Medical Research (ICMR), Directorate General of Health Services and All India Institute of Medical Sciences (AIIMS). The task force last met on January 5 to revise the Clinical Guidelines Protocol for the Treatment of Adult Patients.
Read also: 76 cases of new form of Covid XBB 1.16 found in India, revealed in INSACOG data
